Country Performance
Access to SMA medicines
Roche - Evrysdi
goodto improvenot goodearly access programnot authorised or not availablemissing data
Stay updated!
Newsletter sign up
Keep up-to-date with the OdySMA project. Sign up to receive our digital newsletter
